Petrus Bekker, SVP of Medical & Clinical at ChemoCentryx, Inc. (CCXI), sold 1,021 shares at $14.00 ($14K) on 2013-04-01, disclosed to the SEC on 2013-04-02.
Scheduled sale ($14k) by SVP of Medical & Clinical under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.00 | 957 | $13K | 93.7% |
| 2 | $14.00 | 64 | $896 | 6.3% |
| Total | $14.00 avg | 1,021 | $14K | 100% |
| Filing → |
| CCXI | SELL | 2017-06-30 | $760K | — | Filing → |
| CCXI | SELL | 2016-12-20 | $134K | — | Filing → |
| CCXI | SELL | 2016-12-07 | $255K | — | Filing → |